Recombinant Zoster Vaccination May Reduce Dementia Risk in Older Adults
1. In this target trial emulation, receipt of the recombinant zoster vaccine (RZV) was associated with a reduced risk of ...
Tag: Shingles (Herpes Zoster)
New herpes zoster vaccine predicted to be more cost effective than predecessor
1. In a computational model, the new “recombinant zoster vaccine” (RZV) was predicted to be most cost-effective than the previous ...
Herpes zoster subunit vaccine may be more cost-effective than live attenuated zoster vaccine
1. The new adjuvanted herpes zoster subunit vaccine was more efficacious and less expensive for all ages at the price ...
Herpes zoster subunit vaccine safe and highly effective in adults over 70: The ZOE-70 trial
1. The herpes zoster subunit vaccine (HZ/su) demonstrated age-independent efficacy and significantly reduced the incidence of herpes zoster and postherpetic ...
Herpes zoster vaccine not cost-effective for 50 year-old adults
1. From a model, the incremental cost-effectiveness ratio between Herpes zoster vaccination and no vaccination at age 50 years was ...
Patient Basics: Shingles (Herpes Zoster)
Originally published by Harvard Health. What Is It? Shingles, also known as herpes zoster or just zoster, occurs when a virus ...
